Varun Aggarwal1, Christopher J. Petit2, Andrew C. Glatz3，4, Bryan H. Goldstein5, Athar M. Qureshi1
Congenital Heart Disease, Vol.14, No.1, pp. 110-115, 2019, DOI:10.1111/chd.12709
Abstract The use of prostaglandin‐E1 immediately after birth and subsequent surgical crea‐
tion of the modified Blalock‐Taussig shunt (BTS) shunt have remarkably improved the
prognosis and survival of children with congenital heart disease and ductal‐depend‐
ent pulmonary blood flow (PBF). Despite the advancement in surgical techniques,
bypass strategies, and postoperative management, significant morbidity and mortal‐
ity after BTS still remain. Patent ductus arteriosus stenting has been shown to be as
an acceptable alternative to BTS placement in select infants with ductal‐dependent
PBF. Newer procedural techniques and equipment, along with operator experience
have all contributed to procedural More >
Login
Register
